These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 4213507)

  • 1. Toxicity of camptothecin (NSC-100880).
    Schaeppi U; Fleischman RW; Cooney DA
    Cancer Chemother Rep 3; 1974 Sep; 5(1):25-36. PubMed ID: 4213507
    [No Abstract]   [Full Text] [Related]  

  • 2. Preclinical toxicology studies with ICRF-159 (NSC-129943)--a new antineoplastic drug.
    Gralla EJ; Coleman GL; Jonas AM
    Cancer Chemother Rep 3; 1974 Sep; 5(1):1-7. PubMed ID: 4213305
    [No Abstract]   [Full Text] [Related]  

  • 3. Preclinical toxicology of alpha-2'-deoxythioguanosine (NSC-71851).
    Henry MC; DiDomenico E
    Cancer Chemother Rep 3; 1974 Sep; 5(1):9-14. PubMed ID: 4213304
    [No Abstract]   [Full Text] [Related]  

  • 4. Preclinical toxicologic evaluation of 2,5-piperazinedione, 3,6-bis(5-chloro-2-piperidyl),-dihydrochloride (NSC-135758) in dogs and monkeys.
    Folk RM; Peters AC; Pavkov KL; Swenberg JA
    Cancer Chemother Rep 3; 1974 Sep; 5(1):37-41. PubMed ID: 4213303
    [No Abstract]   [Full Text] [Related]  

  • 5. 4-Week repeated intravenous dose toxicity study of a new camptothecin anticancer agent CKD-602 in dogs.
    Kim JC; Shin DH; Park SH; Park SC; Kim YB; Kim HC; Cha SW; Cho KH; Kang BH; Chung MK
    Food Chem Toxicol; 2005 May; 43(5):699-706. PubMed ID: 15778009
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vincristine (NSC-67574): a retrospective toxicologic evaluation in monkeys and dogs using weekly intravenous injections for 6 weeks.
    Folk RM; Peters AC; Pavkov KL; Swenberg JA
    Cancer Chemother Rep 3; 1974 Sep; 5(1):17-23. PubMed ID: 4213529
    [No Abstract]   [Full Text] [Related]  

  • 7. Preclinical toxicity of a geldanamycin analog, 17-(dimethylaminoethylamino)-17-demethoxygeldanamycin (17-DMAG), in rats and dogs: potential clinical relevance.
    Glaze ER; Lambert AL; Smith AC; Page JG; Johnson WD; McCormick DL; Brown AP; Levine BS; Covey JM; Egorin MJ; Eiseman JL; Holleran JL; Sausville EA; Tomaszewski JE
    Cancer Chemother Pharmacol; 2005 Dec; 56(6):637-47. PubMed ID: 15986212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amelioration of the side effects of cyclophosphamide.
    Hussey JL; Kisken WA
    Surg Forum; 1970; 21():109-11. PubMed ID: 4328377
    [No Abstract]   [Full Text] [Related]  

  • 9. Evaluation of the toxic potentials of a new camptothecin anticancer agent CKD-602 on fertility and early embryonic development in rats.
    Chung MK; Han SS; Kim JC
    Regul Toxicol Pharmacol; 2006 Aug; 45(3):273-81. PubMed ID: 16814440
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preclinical toxicologic studies of -thioguanine deoxyriboside (NSC-71261).
    Henry MC; Morrison RK; Brown DE; Marlow M; Davis R; Cooney DA
    Cancer Chemother Rep 3; 1973 Jan; 4(1):41-9. PubMed ID: 4634118
    [No Abstract]   [Full Text] [Related]  

  • 11. cis-Dichlorodiammineplatinum(II) (NSC-119 875): preclinical toxicologic evaluation of intravenous injection in dogs, monkeys and mice.
    Schaeppi U; Heyman IA; Fleischman RW; Rosenkrantz H; Ilievski V; Phelan R; Cooney DA; Davis RD
    Toxicol Appl Pharmacol; 1973 Jun; 25(2):230-41. PubMed ID: 4197634
    [No Abstract]   [Full Text] [Related]  

  • 12. CCNU (NSC-79037): preclinical toxicologic evaluation of a single intravenous infusion in dogs and monkeys.
    Schaeppi U; Fleischman RW; Phelan RS; Ethier MF; Luthra YK
    Cancer Chemother Rep 3; 1974 Sep; 5(1):53-64. PubMed ID: 4213020
    [No Abstract]   [Full Text] [Related]  

  • 13. Inhibitory activity of camptothecin derivatives against acetylcholinesterase in dogs and their binding activity to acetylcholine receptors in rats.
    Kawato Y; Sekiguchi M; Akahane K; Tsutomi Y; Hirota Y; Kuga H; Suzuki W; Hakusui H; Sato K
    J Pharm Pharmacol; 1993 May; 45(5):444-8. PubMed ID: 8099964
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of malignant melanoma with camptothecin (NSC-100880).
    Gottlieb JA; Luce JK
    Cancer Chemother Rep; 1972 Feb; 56(1):103-5. PubMed ID: 5030802
    [No Abstract]   [Full Text] [Related]  

  • 15. [Toxicological studies on ipratropiumbromide (author's transl)].
    Sarafana L; Clark GC; Stötzer H
    Arzneimittelforschung; 1976; 26(5a):985-9. PubMed ID: 134729
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Parameters of the acute toxicity and cumulative properties of kanamycin].
    Zel'tser IZ; Lysenko TSh; Shtegel'man LA
    Antibiotiki; 1974 Jun; 19(6):552-6. PubMed ID: 4849342
    [No Abstract]   [Full Text] [Related]  

  • 17. Preclinical toxicologic evaluation of tetrahydrouridine (NSC-112907) in beagle dogs and rhesus monkeys.
    Goldenthal EI; Cookson KM; Geil RG; Wazeter FX
    Cancer Chemother Rep 3; 1974 Sep; 5(1):15-6. PubMed ID: 4213302
    [No Abstract]   [Full Text] [Related]  

  • 18. Capecitabine and irinotecan as first-line treatment of advanced colorectal cancer.
    Punt CJ; Koopman M
    J Clin Oncol; 2008 Apr; 26(11):1907-8; author reply 1908-9. PubMed ID: 18398161
    [No Abstract]   [Full Text] [Related]  

  • 19. Toxicity of neocarzinostatin (NSC-69856): an antitumor antibiotic with radiomimetic and antigenic characteristics.
    Schaeppi U; Menninger F; Fleischman RW; Bogden AE; Schein PS; Cooney DA
    Cancer Chemother Rep 3; 1974 Sep; 5(1):43-52. PubMed ID: 4213508
    [No Abstract]   [Full Text] [Related]  

  • 20. Phase I pharmacological and bioavailability study of oral diflomotecan (BN80915), a novel E-ring-modified camptothecin analogue in adults with solid tumors.
    Gelderblom H; Salazar R; Verweij J; Pentheroudakis G; de Jonge MJ; Devlin M; van Hooije C; Seguy F; Obach R; Pruñonosa J; Principe P; Twelves C
    Clin Cancer Res; 2003 Sep; 9(11):4101-7. PubMed ID: 14519632
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.